Pluristem Therapeutics Inc (PSTI)

[caltrials]

The fact that physicians and patients have been asking for PLX to treat COVID on a compassionate use basis has been known for some time. The first compassionate treatments seemed to work very well. It appeared that patients who were doomed to die in fact survived.

And then with the advent of clinical trials the company announced that it would not comment further on the compassionate use results. From the announcement about not commenting, it seems true that they have not commented on the results. BUT, the fact that they have not stopped the compassionate use and the fact that the drug is being sought by literally hundreds of MD's seems to be sending a clear message. If there were a lot of adverse results the medical community would not be seeking the drug nor would Pluristem continue to provide it. Here is the problem. We don't know what the companies response to the requests for compassionate use has been. What we do know clearly is that somebody for their own reasons has come on board and loaded up with some 35M worth of the stock.

In the Big Book of Alcoholics Anonymous there is a great lesson that rings true today. Bill W. made a lot of money by being "boots on the ground". He would take trips and see what was going on by talking to employees, by counting cars in parking lots and by being observant. I have long followed that insight. I suspect that even though the company is not commenting publicly about the compassionate use amounts or results, you can be darn sure that any Dr. working in the field of COVID treatment is closely tied into the working community. If PLX cells are working, the word is getting around.

I am for the first time in many years solidly bullish about Pluristem. It seems that the COVID-19 virus may be accomplishing what PSTI management could not do. That is moving towards the market.